HTL0039732 in Participants With Advanced Solid Tumours
收藏NIAID Data Ecosystem2026-05-01 收录
官方服务：
资源简介：
The purpose of this trial is to evaluate a new drug, HTL0039732, that will be administered on its own (as a monotherapy) and in combination with atezolizumab or with other approved anti-cancer therapies, in participants with advanced solid tumours.
创建时间：
2023-07-15
